Evidence map›Paper›PMID 36172879›Full record

ArticleJournal of cellular and molecular medicine2022

Neuropeptide Y regulates cholesterol uptake and efflux in macrophages and promotes foam cell formation.

Yu Cai, Zhengchao Wang, Lun Li, Li He, Xinying Wu, Mingjing Zhang, Pengfei Zhu

Open access · goldAbstract read
In one paragraph

Article in Journal of cellular and molecular medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.1field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Research Status and Latest Progress in the Regulatory Mechanisms of ABCA1.International journal of molecular sciences · 2025
    Review
  3. Miconazole attenuates LPS-induced lung inflammation by modulating alveolar macrophage polarization via promoting lipid metabolic reprogramming.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2025
    Article
  4. Review
  5. Article
  6. Etiology of lipid-laden macrophages in the lung.International immunopharmacology · 2023
    Review
  7. Neuropeptide Y Peptide Family and Cancer: Antitumor Therapeutic Strategies.International journal of molecular sciences · 2023
    Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Yu CaiDepartment of Rehabilitation, Wuhan Fourth Hospital, Wuhan, China.ORCID 0000-0003-3967-8727
Zhengchao WangDepartment of Orthopedics, Tongji Medical College, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, China.
Lun LiDepartment of Cardiology, Wuhan Fourth Hospital, Wuhan, China.
Li HeDepartment of Cardiology, Wuhan Fourth Hospital, Wuhan, China.
Xinying WuDepartment of Cardiology, Wuhan Fourth Hospital, Wuhan, China.
Mingjing ZhangDepartment of Cardiology, Wuhan Fourth Hospital, Wuhan, China.
Pengfei ZhuDepartment of Cardiology, Wuhan Fourth Hospital, Wuhan, China.
Wuhan Puai Hospital · CNTongji Hospital · CN

Funding

Health Commission of Hubei Province Scientific Research Project WJ2019H371National Natural Science Foundation of Hubei 2019CFB806National Natural Science Foundation of Wuhan WX19Q24
6 · The paper itself

Abstract

The dysregulation of lipid metabolic pathways (cholesterol uptake and efflux) in macrophages results in the formation of lipid-dense macrophages, named foam cells, that participate in plaque formation. NPY binding to NPY receptors in macrophages can modulate cell functions and affect the process of atherosclerotic plaques. The present study aimed to determine whether NPY affects the formation of macrophage-derived foam cells and its underlying mechanisms in macrophages. THP-1-derived macrophages were incubated with oxidized low-density lipoprotein (ox-LDL) and treated with different concentrations of NPY. We analysed the relative levels of proteins related to cholesterol uptake and efflux. We found that NPY effectively increased cholesterol uptake and intracellular cholesterol content via the Y1 and Y5 receptors, and this effect was blocked by Y1 and Y5 antagonists. Mechanistically, NPY enhanced the expression of SRA and CD36 via the PKC/PPARγ pathways, promoting macrophage cholesterol uptake. Moreover, NPY significantly decreased cholesterol efflux to the extracellular cholesterol acceptors ApoA1 and HDL in macrophages. NPY mediated decreases in ABCA1, ABCG1 and SR-BI expression through the inhibition of the JAK/STAT3 pathways. Our results suggest that NPY binding to the Y1 and Y5 receptors enhances foam cell formation by regulating cholesterol uptake and efflux in macrophages.

Indexed as

AtherosclerosisFoam CellsCD36 AntigensCholesterolHumansLipoproteins, LDLMacrophagesNeuropeptide YCD36 AntigensCholesterolLipoproteins, LDLNeuropeptide Yfoam cellmacrophageNPYTHP-1

Identifiers

PMID36172879
PMCPMC9639043
OpenAlexW4297965055

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.